MedTrace Logo

Tradipitant for Functional Dyspepsia

NCT05653310 · Status: ENROLLING_BY_INVITATION · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-01-20

No results posted yet for this study

Summary

To evaluate the effects of tradipitant relative to placebo on gastric motor functions, satiation, and postprandial symptoms in patients with functional dyspepsia.

Conditions

  • Functional Dyspepsia

Interventions

DRUG

Tradipitant

Tradipitant Capsule

DRUG

Placebo

Placebo Capsule

Sponsors & Collaborators

  • Mayo Clinic

    collaborator OTHER

  • Xiao Jing (Iris) Wang

    lead OTHER

Principal Investigators

  • Xiao Jing (Iris) Wang, MD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-09
Primary Completion
2026-06-30
Completion
2026-06-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05653310 on ClinicalTrials.gov